Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Suit Over Inspire V Rollout

Overview

• The putative class action covers purchases of Inspire Medical Systems stock from August 6, 2024 through August 4, 2025.
• The case, pending in the U.S. District Court for the District of Minnesota, is captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc.
• Filings allege the company misrepresented demand and operational readiness for the Inspire V device, citing incomplete training and onboarding at many centers.
• Company disclosures note claims-processing software updates only took effect July 1, 2025, which meant implanting centers could not bill for Inspire V procedures before that date.
• On August 4, 2025 the company flagged an elongated rollout timeframe, cut EPS guidance to $0.40–$0.50 from $2.20–$2.30, and the stock fell about 32% the next day.